Viewing nowPelogen 20 mg (Memantine Hydrochloride)
Memantine Hydrochloride 20mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

MFDS item code 202401820 · Approved 2024.07.29 · Insurance code 651905350
Treatment of moderate to severe Alzheimer's disease
This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps improve the patient's memory and cognitive function and reduces difficulties in daily life. Additionally, it plays a role in slowing the progression of symptoms, thereby enhancing quality of life. By taking it consistently, the patient's condition can be maintained in a stable manner.
This medicine is administered orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. It may be taken with or without food. The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1–7) Administer 5mg daily for 7 days. Week 2 (Days 8–14) Administer 10mg daily for 7 days. Week 3 (Days 15–21) Administer 15mg daily for 7 days. From Week 4 onward Administer 20mg daily. The recommended maintenance dose is 20mg daily. Based on clinical data, the recommended dose in patients 65 years of age and older is 20mg daily. No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10mg. No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.
This medication should not be used in patients with a known allergy to its ingredients. It should also not be administered to patients with severe liver function impairment or significantly reduced kidney function. Caution should be exercised when used in patients with epilepsy or a history of seizures, or in those prone to seizures. The risk of side effects may increase when used with other specific medications, especially those acting on NMDA receptors; therefore, it is advisable to avoid concurrent use. In situations where urinary acidity (pH) may change, careful monitoring of the patient's condition is required. Caution is advised in patients with heart disease or uncontrolled hypertension, as the safety of this medication in such patients has not been adequately confirmed. While taking this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur. Central nervous system symptoms like confusion, hallucinations, or seizures can also rarely occur, so any unusual symptoms should prompt immediate consultation with a physician. Interaction with other medications is possible; therefore, patients taking anticoagulants, skeletal muscle relaxants, or antipsychotic drugs should inform their doctor or pharmacist. Pregnant women or those who may become pregnant should consult their physician before taking this medication, and breastfeeding should be discontinued if the patient is nursing. The safety and efficacy of this medication in individuals under 18 years of age have not been established, and its use is not recommended in this population. In cases of overdose, central nervous system symptoms and gastrointestinal symptoms may occur, requiring immediate appropriate treatment in a hospital. This medication may reduce reaction times and attention, so caution is advised during driving or operation of machinery. Keep out of reach of children and do not transfer the medication to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture and kept at room temperature between 1 and 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be well maintained.
Pink oval film-coated tablet
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 20mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.